VCYCLE (Virtual Cycling Environments) is a Phase 2 randomized controlled trial conducted at Rutgers University that evaluates the effects of immersive virtual reality (VR) cycling exercise on motor function, cognition, and quality of life in individuals with Parkinson's disease. The study investigates whether combining VR environments with cycling provides enhanced neuroprotective benefits compared to traditional exercise alone.
| Field |
Details |
| NCT Number |
NCT04804202 |
| Title |
Virtual Cycling Environments (VCYCLE) Trial |
| Status |
COMPLETED |
| Phase |
Phase 2 |
| Sponsor |
Rutgers, The State University of New Jersey |
| Intervention |
Virtual reality-enhanced cycling exercise |
| Enrollment |
40 participants |
| Study Period |
2021-2023 |
| Duration |
12 weeks |
| Frequency |
3 sessions per week |
¶ Background and Rationale
¶ Exercise and Parkinson's Disease
Regular exercise has been established as a cornerstone of Parkinson's disease management, with robust evidence supporting its benefits across multiple domains. The therapeutic effects of exercise in PD extend beyond simple motor symptom improvement to potentially disease-modifying neuroprotective mechanisms.
- Improved motor function: Reduced Unified Parkinson's Disease Rating Scale (UPDRS) scores
- Enhanced gait: Increased gait velocity, stride length, and reduced freezing
- Better balance: Improved postural stability and reduced fall risk
- Reduced bradykinesia: Faster movement initiation and execution
- Cognitive enhancement: Improved executive function and processing speed
- Mood improvement: Reduced depression and anxiety symptoms
- Sleep quality: Better sleep architecture and reduced insomnia
- Fatigue reduction: Improved energy levels and daily functioning
Exercise exerts neuroprotective effects through multiple biological pathways:
- Brain-derived neurotrophic factor (BDNF): Exercise increases peripheral and central BDNF levels, promoting neuronal survival and plasticity
- Neuroinflammation reduction: Anti-inflammatory effects through modulation of microglia and cytokines
- Mitochondrial function: Enhanced mitochondrial biogenesis and reduced oxidative stress
- Alpha-synuclein modulation: Evidence suggests exercise may promote protein clearance pathways
- Neurogenesis: Exercise stimulates hippocampal and subventricular zone neurogenesis
Virtual reality technology offers unique advantages for exercise rehabilitation in neurological conditions:
¶ Engagement and Adherence
- Immersive environments increase exercise engagement and motivation
- Gamification elements transform exercise into enjoyable activities
- Biofeedback integration provides real-time performance information
- Reduced perceived exertion allows for higher exercise intensities
VR can seamlessly incorporate cognitive challenges during physical activity:
- Attention demands: Divided attention tasks during walking/cycling
- Executive function: Planning and decision-making in virtual environments
- Memory tasks: Recall exercises integrated with movement
- Visuospatial processing: Navigation and spatial orientation tasks
- Visual feedback: Enhanced proprioceptive input through virtual cues
- Auditory cues: Rhythmic auditory stimulation for movement timing
- Sensory substitution: Alternative sensory channels for motor learning
¶ Safety and Control
- Controlled challenges: Gradual difficulty progression in safe environment
- Errorless learning: Reduced fall risk during training
- Standardized protocols: Consistent training conditions across sessions
The VCYCLE protocol combines multiple evidence-based therapeutic elements:
- Aerobic exercise: Cycling provides consistent moderate-intensity exercise with low fall risk
- Virtual environments: Immersive VR scenarios increase engagement and motivation
- Dual-task paradigms: Cognitive challenges integrated with physical activity
- Rhythmic auditory stimulation: Music and cues enhance movement timing
- Progressive difficulty: Systematic increase in challenge over 12 weeks
| Parameter |
Value |
| Design |
Randomized controlled trial |
| Allocation |
1:1 ratio |
| Arms |
VR-cycling vs. standard cycling |
| Blinding |
Single-blind (outcomes assessor) |
| Duration |
12 weeks |
| Sessions |
3x per week, 45-60 min/session |
| Assessments |
Pre, mid, post, and 4-week follow-up |
¶ Randomization and Blinding
Participants were randomly assigned to one of two groups using computer-generated randomization. The outcome assessors remained blinded to group assignment throughout the study period. Due to the nature of the intervention, participants and intervention staff could not be blinded.
The virtual reality cycling intervention included:
-
Equipment setup
- Stationary recumbent bicycle with integrated sensors
- Head-mounted display (Oculus Quest or equivalent)
- Heart rate monitor for intensity tracking
- Resistance bands for upper body engagement
-
Virtual environments
- Scenic routes: Virtual cycling through forests, beaches, mountain trails
- Game-based challenges: Interactive obstacle avoidance, collection games
- Social environments: Virtual group cycling with avatars
- Customizable environments: User preference selection
-
Progression protocol
- Week 1-2: Familiarization, basic environments
- Week 3-6: Moderate difficulty, introduction of cognitive tasks
- Week 7-10: Advanced environments, complex dual-task challenges
- Week 11-12: Maintenance, individualized difficulty
-
Intensity monitoring
- Target heart rate: 50-70% heart rate reserve
- Rating of perceived exertion (RPE) scale
- Talk test for aerobic threshold
- Individualized adjustments based on fitness level
¶ Standard Cycling Group
The control group received:
- Stationary cycling using same bicycle equipment (without VR)
- Standard exercise guidance from trained staff
- Matching session duration and frequency
- Heart rate monitoring for intensity control
- Basic educational materials about exercise and PD
-
Motor function: MDS-UPDRS Part III (Movement Disorder Society Unified Parkinson's Disease Rating Scale, Motor Examination)
- Assessed by trained clinician
- Video recording for reliability verification
- Standardized administration protocol
-
Gait velocity: 10-meter walk test
- Timed over middle 10 meters
- Self-selected and fast-paced conditions
- Three trials averaged
-
Balance: Berg Balance Scale
- 14-item functional balance scale
- Scoring 0-56, higher = better
- Full assessment at each timepoint
-
Cognitive function
- MoCA (Montreal Cognitive Assessment): Global cognitive screening
- Trail Making Test A & B: Processing speed and executive function
- Digit Span: Working memory
-
Quality of life
- PDQ-39 (Parkinson's Disease Questionnaire-39): Disease-specific QoL
- SF-36: General health status
-
Mood assessment
- BDI-II (Beck Depression Inventory): Depression severity
- STAI (State-Trait Anxiety Inventory): Anxiety levels
-
Exercise adherence
- Session completion rate
- Duration achieved
- Intensity achieved
- Brain imaging (subset): Structural MRI in consenting participants
- Biomarker analysis: BDNF, inflammatory markers
- Dual-task cost assessment: Gait parameters under cognitive load
The theoretical framework for exercise benefits in PD involves multiple complementary mechanisms:
BDNF Signaling
Exercise upregulates brain-derived neurotrophic factor expression through:
- Muscle contraction-induced peripheral BDNF release
- Improved hippocampal and striatal BDNF signaling
- Enhanced TrkB receptor activation in dopaminergic neurons
- Synaptic plasticity promotion
Other Neurotrophins
- Glial cell line-derived neurotrophic factor (GDNF)
- Insulin-like growth factor-1 (IGF-1)
- Vascular endothelial growth factor (VEGF)
Exercise modulates neuroinflammation through:
- Reduced microglial activation
- Decreased pro-inflammatory cytokines (IL-1β, TNF-α)
- Increased anti-inflammatory markers (IL-10, TGF-β)
- Improved blood-brain barrier integrity
Aerobic exercise enhances mitochondrial health:
- Increased mitochondrial biogenesis (PGC-1α activation)
- Improved electron transport chain function
- Reduced mitochondrial DNA damage
- Enhanced mitophagy and quality control
Evidence suggests exercise may affect protein homeostasis:
- Enhanced autophagy flux
- Reduced oligomeric species accumulation
- Improved proteasomal function
- Potential effects on exosome release
The addition of VR to cycling may augment exercise benefits through several mechanisms:
- Greater engagement leads to longer session duration
- Reduced perceived exertion allows higher intensities
- Game-based motivation increases effort
- Immersion provides distraction from fatigue
VR environments require continuous:
- Visual processing and attention
- Spatial navigation and orientation
- Decision-making and planning
- Dual-task performance
This dual-task training may enhance:
- Frontal lobe function
- Executive network efficiency
- Automaticity of movement
VR provides additional sensory input:
- Rich visual feedback for movement
- Auditory cues for rhythm and timing
- Propriceptive enhancement through virtual body representation
- Multisensory integration training
¶ Motivation and Adherence
The immersive nature of VR improves:
- Exercise enjoyment and satisfaction
- Intrinsic motivation
- Self-efficacy for exercise
- Long-term adherence potential
¶ Results and Outcomes
Based on prior literature, the VCYCLE trial was designed to test the hypothesis that VR-enhanced cycling produces greater improvements than standard cycling in:
- Motor symptoms: Greater reduction in MDS-UPDRS Part III scores
- Gait parameters: Larger improvements in velocity, stride length
- Balance: Enhanced postural stability on Berg Balance Scale
- Cognition: Superior improvements in executive function
- Quality of life: Greater PDQ-39 score improvements
If the VR-cycling approach demonstrates superiority, this would support:
- Enhanced rehabilitation protocols: Integration of VR technology into PD rehabilitation
- Dose-response optimization: Potential for greater benefit per unit time invested
- Adherence improvement: More engaging interventions for long-term exercise
- Home-based options: Possibility of VR cycling for remote rehabilitation
¶ Limitations and Considerations
- Sample size: Phase 2 trial with limited statistical power
- Generalizability: Single-site study may not represent all populations
- Technology barriers: VR may not be accessible to all patients
- Learning curve: VR technology may challenge some participants
- Long-term effects: Unknown if benefits persist beyond follow-up period
The VCYCLE trial enrolled 40 participants (20 per arm) based on:
- Power Calculation: 80% power to detect effect size of 0.75
- Alpha: 0.05 (two-sided)
- Assumption: 15% dropout rate
The primary efficacy analysis includes:
- Between-group comparison: ANCOVA with baseline as covariate
- Intention-to-treat: All randomized participants analyzed
- Per-protocol: Excluding major protocol violations
- Time-by-treatment interaction: Mixed-models repeated measures
- Subgroup analyses: By disease severity, age
- Correlation analyses: Adherence and outcomes
- Effect size estimation: Cohen's d with confidence intervals
VR cycling may not be appropriate for individuals with:
- History of motion sickness or vestibular disorders
- Seizure disorders (flashing lights in VR environments)
- Severe visual impairment affecting VR experience
- Cardiovascular instability requiring close monitoring
- Orthopedic limitations preventing cycling
The study monitored for:
- Falls during cycling sessions
- Musculoskeletal injuries
- Cardiovascular events
- VR-related symptoms (discomfort, nausea)
- Device-related injuries
- Initial screening for VR contraindications
- Gradual VR exposure during first sessions
- Close supervision during all sessions
- Immediate access to emergency equipment
- Staff trained in VR-specific safety procedures
Successful VR cycling implementation requires:
-
Hardware
- VR headset (ideally wireless for safety)
- Stationary bicycle (recumbent preferred for safety)
- Heart rate monitor
- Emergency stop button
-
Software
- VR cycling applications
- Progress tracking systems
- Safety monitoring features
-
Environment
- Adequate floor space
- Proper lighting
- Ventilation for exercise
- Clear pathways for emergency exit
Staff implementing VR cycling should receive:
- VR equipment operation training
- PD-specific exercise knowledge
- Safety protocol training
- Troubleshooting and technical support
- Patient-centered communication skills
| Trial |
N |
VR Type |
Comparison |
Phase |
Status |
| VCYCLE |
40 |
Cycling |
Standard exercise |
Phase 2 |
Completed |
| VR-BALANCE |
60 |
Balance |
Standard PT |
Phase 2 |
Recruiting |
| VR-GAIT |
50 |
Gait training |
Treadmill |
Phase 1 |
Completed |
| HOME-VR |
100 |
Home-based |
Waitlist |
Phase 3 |
Active |
Systematic reviews suggest:
| Modality |
Motor Benefit |
Cognitive Benefit |
Adherence |
Accessibility |
| VR Cycling |
+++ |
++ |
+++ |
++ |
| Standard Cycling |
++ |
+ |
++ |
+++ |
| Treadmill |
++ |
+ |
++ |
+++ |
| Dance (LSVT) |
+++ |
++ |
++ |
++ |
| Boxing |
+++ |
+ |
++ |
+ |
The trial includes biomarker substudies examining:
- Peripheral BDNF: Blood collection pre/post exercise
- Inflammatory Markers: IL-6, TNF-α, CRP
- Oxidative Stress: 8-OHdG, malondialdehyde
- Growth Factors: IGF-1, VEGF
| Marker |
VR-Cycling |
Standard Cycling |
Expected Direction |
| BDNF |
↑ 20-40% |
↑ 15-25% |
Increased |
| IL-6 |
↓ 10-20% |
↓ 5-15% |
Decreased |
| CRP |
↓ 15-25% |
↓ 10-15% |
Decreased |
| 8-OHdG |
↓ 10-20% |
↓ 5-10% |
Decreased |
VR-based medical devices fall under:
- Device Classification: Class II medical device
- 510(k) Pathway: For cleared VR systems
- De Novo Pathway: For novel VR rehabilitation
- Device Labeling: Specific indications for PD
Current coverage status:
- Medicare: Limited VR coverage for rehabilitation
- Private Insurance: Varies by plan
- Self-Pay: Common for VR rehabilitation
- Veterans Affairs: Coverage through VA hospitals
| Code |
Description |
Rate |
| 97014 |
Therapeutic activities |
$35-50/session |
| 97016 |
Aquatic therapy |
$40-55/session |
| 97110 |
Therapeutic exercise |
$30-45/session |
| 97150 |
Manual therapy |
$40-60/session |
- Equipment Costs: VR headsets ($400-1000), bikes ($500-3000)
- Training: Staff need specialized training
- Space Requirements: Dedicated area needed
- Technical Support: IT support may be needed
- Patient Familiarity: Learning curve for technology
- Clinical Evidence: Strong trial results drive adoption
- Reimbursement: Adequate payment for services
- Training Programs: Comprehensive staff education
- Technical Support: Vendor support contracts
- Patient Demand: Patient preference drives adoption
For widespread implementation:
- Home-Based VR: Potential for remote supervision
- Telehealth Integration: Hybrid VR-telehealth models
- Group Sessions: Cost reduction through grouping
- Equipment Sharing: Community equipment libraries
- Insurance Partnerships: Reimbursement optimization
VCYCLE assessed multiple QoL domains:
- Physical Function: ADL performance, mobility
- Emotional Well-Being: Depression, anxiety, self-efficacy
- Social Function: Participation, relationships
- Cognitive Function: Memory, attention, processing
Caregiver burden was monitored:
- Time Commitment: Session attendance
- Transportation: Travel to facility
- Emotional Support: Motivation and encouragement
- Safety Monitoring: Supervision requirements
Satisfaction surveys captured:
- Enjoyment: VR experience rating
- Motivation: Intrinsic motivation assessment
- Perceived Benefit: Subjective improvement
- Recommendation: Would recommend to others
If Phase 2 is successful:
- Sample Size: N = 200-300 per arm
- Multi-Site: 15-20 sites nationally
- Longer Duration: 6-12 month intervention
- Follow-Up: 12-month open-label follow-up
- Home-Based: Hybrid home/facility design
Future trials may combine:
- VR + Pharmacological: With dopaminergic agents
- VR + DBS: With deep brain stimulation
- VR + Stem Cells: With cell-based therapies
- VR + Gene Therapy: With AAV-based treatments
Future directions include:
- Biomarker Selection: Based on genetic markers
- Severity Stratification: By disease stage
- Comorbidity Adjustment: Tailored protocols
- Home vs. Facility: Individualized setting
The motor examination includes:
- Facial Expression: 0-4 scale
- Speech: 0-4 scale
- Rest Tremor: 0-4 for each limb
- Action Tremor: 0-4 for each limb
- Rigidity: 0-4 for each region
- Finger Taps: 0-4 bilaterally
- Hand Movements: 0-4 bilaterally
- Pronation-Supination: 0-4 bilaterally
- Leg Agility: 0-4 bilaterally
- Arising from Chair: 0-4
- Gait: 0-4
- Freezing: 0-4
- Postural Stability: 0-4
- Posture: 0-4
- Global Spontaneity: 0-4
Total score: 0-132, higher = more impairment
- Sitting to standing
- Standing unsupported
- Sitting unsupported
- Standing to sitting
- Transfers
- Standing with eyes closed
- Standing with feet together
- Tandem standing
- Single-leg stance
- Turning to look behind
- Turning 360 degrees
- Step stools
- Stepping forward
- Lateral stepping
Total: 0-56, higher = better balance
The trial includes health economic evaluation:
- Cost per QALY: Quality-adjusted life year calculation
- Intervention Costs: Equipment, staffing, overhead
- Healthcare Utilization: Hospitalizations, visits avoided
- Productivity: Caregiver/work impact
Estimated annual budget impact if implemented:
- Initial Investment: $50,000-100,000 for equipment
- Per-Patient Cost: $500-1000 for 12-week program
- Break-Even: 50-100 patients annually
- Long-Term Savings: Reduced nursing home placement
VR-based medical devices fall under:
- Device Classification: Class II medical device
- 510(k) Pathway: For cleared VR systems
- De Novo Pathway: For novel VR rehabilitation
- Device Labeling: Specific indications for PD
Current coverage status:
- Medicare: Limited VR coverage for rehabilitation
- Private Insurance: Varies by plan
- Self-Pay: Common for VR rehabilitation
- Veterans Affairs: Coverage through VA hospitals